Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00415-021-10428-6 http://scihub22266oqcxt.onion/10.1007/s00415-021-10428-6 33537898!7857861!33537898     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Neurol 2021 ; 268 (9): 3125-3128 Nephropedia Template TP {{tp|p=33537898|t=2021. Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19 |pdf=|usr=}}{{33537898}} gab.com Text Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19 JO: J Neurol http://www.kidney.de/pget.php?&tw=1&pmid=33537898 #FOAvip We report on a patient with refractory Myasthenia gravis with acetylcholine receptor antibodies with two prior myasthenic crises suffering from COVID-19 with rapid evolving weakness and respiratory failure. Respiratory failure developed and prolonged mechanical ventilation was necessary. After plasmapheresis, residual, severe generalized and bulbar weakness persisted. Complement inhibition with eculizumab was, therefore, introduced and lead to rapid recovery. In refractory myasthenic crisis individualised therapies could be successful. Twit Text FOAVip Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19 ????J Neurol http://www.kidney.de/pget.php?&tw=1&pmid=33537898 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33537898 #FOAvip English Wikipedia <ref>{{Cite pmid|33537898}}</ref> Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19 #MMPMID33537898 Hofstadt-van Oy U; Stankovic S; Kelbel C; Oswald D; Larrosa-Lombardi S; Barchfeld T; Cleff U J Neurol 2021[Sep]; 268 (9): 3125-3128 PMID33537898show ga We report on a patient with refractory Myasthenia gravis with acetylcholine receptor antibodies with two prior myasthenic crises suffering from COVID-19 with rapid evolving weakness and respiratory failure. Respiratory failure developed and prolonged mechanical ventilation was necessary. After plasmapheresis, residual, severe generalized and bulbar weakness persisted. Complement inhibition with eculizumab was, therefore, introduced and lead to rapid recovery. In refractory myasthenic crisis individualised therapies could be successful. |*COVID-19[MESH] |*Myasthenia Gravis/complications/drug therapy[MESH] |*Respiratory Insufficiency[MESH] |Humans[MESH] |Receptors, Cholinergic[MESH]Complement inhibition initiated recovery of a severe myasthenic crisis(epmc).pdf DeepDyve Pubget Overpricing